Rutin protects dopaminergic neurons from oxidative stress in an animal model of parkinson's disease

Neurotoxicity Research

Volumn 22, Issue 1, 2012, Pages 1-15

  Islam, Fakhrul ^a,e   Khan, Mohd Moshahid ^a,b   Raza, Syed Shadab ^a   Javed, Hayate ^a   Ahmad, Ajmal ^a,c   Khan, Andleeb ^a,e   Islam, Farah ^d   Safhi, Mohammed M ^e  

^a HAMDARD UNIVERSITY   (India)

^b UNIVERSITY OF IOWA   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d HAMDARD UNIVERSITY   (India)

^e JAZAN UNIVERSITY   (Saudi Arabia)

Author keywords

6 Hydroxydopamine; Behavioral activity; Inflammation; Oxidative stress; Parkinson's disease; Rutin

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ANTIOXIDANT; ASCORBIC ACID; DOPAMINE; DOPAMINE 2 RECEPTOR; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; OXIDOPAMINE; RUTOSIDE; SODIUM CHLORIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOTOR COORDINATION; MOTOR DYSFUNCTION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; WISTAR RAT;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; INFLAMMATION; MALE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, WISTAR; RUTIN; SUBSTANTIA NIGRA;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 84861456441     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-011-9295-2     Document Type: Article

References (58)

1. Afanas'av IB, Dorozhko AI, Brodskii AV, Kostyuk VA, Potapovich AI (1989) Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem Pharmacol 38:1763-1769 (Pubitemid 19138525)
2. Agrawal AK, Hussin R, Raghubir R, Kumar A, Seth PK (1995) Neurobehavioural, neurochemical and electrophysiological studies in 6-hydroxydopamine lesioned and neural transplanted rats. Int J Dev Neurosci 13:105-111
3. Ahmad M, Saleem S, Ahmad AS, Yousuf S, Ansari MA et al (2005) Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced Parkinsonism in rats: Neurobehavioural, neurochemical and immunohistochemical evidences. J Neurochem 93:94-104 (Pubitemid 40463519)
4. Allbutt HN, Henderson JM (2007) Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease. J Neurosci Methods 159:195-202 (Pubitemid 44908650)
5. Bishnoi M, Chopra K, Kulkarni SK (2007) Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes. Fundam Clin Pharmacol 21:521-529 (Pubitemid 47404330)
6. Blandini F, Armentero MT, Martignoni E (2008) The 6-hydroxydopamine model: News from the past. Parkinsonism Relat Disord 14:S124-S129
7. Blum D, Torch S, Lambengm N, Nissou M, Benabid A, Sadoul R (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA. Dopamine and MPTP: Contribution to apoptotic theory in Parkinson's disease. Prog Neurobiol 65:135-172
8. Cannon JR, Keep RF, Hua Y, Richardson RJ, Schallert T, Xi G (2005) Thrombin preconditioning provides protection in a 6-hydroxydopamine Parkinson's disease model. Neurosci Lett 373:189-194 (Pubitemid 41556556)
9. Carlberg I, Mannervik B (1975) Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem 250:5475-5480
10. Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK (2006) Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Neurobiol Dis 22:421-434
11. Choi DK, Pennathur S, Perier C, Tieu K, Teismann P et al (2005) Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice. J Neurosci 25:6594-6600 (Pubitemid 40995291)
12. Claiborne A (1985) Catalase activity. In: Green Wald RA (ed) CRC hand book of methods for oxygen radical research. CRC Press, Boca Raton, FL, pp 283-284
13. del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ (2000) Inflammation and stroke: Putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 10:95-112 (Pubitemid 30056398)
14. Deumens R, Blokland A, Prickaerts J (2002) Modeling Parkinson's disease in rats: An evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175:303-317 (Pubitemid 34634286)
15. Dringen R (2000) Metabolism and functions of glutathione in brain. Prog Neurobiol 62:649-671 (Pubitemid 30407139)
16. Freeman BA, Crapo JD (1982) Biology of disease: Free radicals and tissue injury. Lab Investig 47:412-426 (Pubitemid 13229679)
17. Gao HM, Kotzbauer PT, Uryu K, Leight S, Trojanowski JQ, Lee VM (2008) Neuroinflammation and oxidation/nitration of alphasynuclein linked to dopaminergic neurodegeneration. J Neurosci 28:7687-7698
18. Gupta R, Singh M, Sharma A (2003) Neuroprotective effect of antioxidants on ischaemia and reperfusion-induced cerebral injury. Pharmacol Res 48:209-215 (Pubitemid 36683170)
19. Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson's disease: A target for neuroprotection? Lancet Neurol 8:382-397
20. Hirsch EC, Breidert T, Rousselet E, Hunot S, Hartmann A, Michel PP (2003) The role of glial reaction and inflammation in Parkinson's disease. Ann NY Acad Sci 991:214-228 (Pubitemid 36793816)
21. Hirsch E, Hunot S, Hartmann A (2005) Neuroinflammatory processes in Parkinson's disease. Parkinsonism Relat Disord 11:S9-S15 (Pubitemid 40693572)
22. Ishrat T, Parveen K, Khan MM, Khuwaja G, Khan MB et al (2009) Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Res 1281:117-127
23. Islam F, Zia S, Sayeed I, Zafar KS, Ahmad AS (2002) Selenium induced alteration on lipids, lipid peroxidation, and thiol group in circadian rhythm centers of rat. Biol Trace Elem Res 90:203-214 (Pubitemid 36110750)
24. Jenner P (2003) Oxidative stress in Parkinson's disease. Ann Neurol 53:S26-S36
25. Jenner P (2007) Oxidative stress and Parkinson's disease. Handb Clin Neurol 83:507-520
26. Jiang ZY, Hunt JV, Wolff SP (1992) Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem 202:384-389
27. Jin F, Wu Q, Lu YF, Gong QH, Shi JS (2008) Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. Eur J Pharmacol 600:78-82
28. Joglar B, Rodriguez-Pallares J, Rodriguez-Perez AI, Rey P, Guerra MJ, Labandeira-Garcia JL (2009) The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: Relevance to progression of the disease. J Neurochem 109:656-669
29. Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR (1974) Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11:151-169
30. Kamalakkannan N, Prince PSM (2006) Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues. Mol Cell Biochem 293:211-219 (Pubitemid 44843016)
31. Khan MM, Ahmad A, Ishrat T, Khuwaja G, Srivastawa P, Khan MB et al (2009) Rutin protects the neural damage induced by transient focal ischemia in rats. Brain Res 1292:123-135
32. Kirik D, Rosenblad C, Bjorklund A (1998) Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol 152:259-277 (Pubitemid 28419264)
33. Koda T, Kuroda Y, Imai H (2008) Protective effect of rutin against spatial memory impairment induced by trimethyltin in rats. Nutr Res 28:629-634
34. Koda T, Kuroda Y, Imai H (2009) Rutin supplementation in the diet has protective effects against toxicant-induced hippocampal injury by suppression of microglial activation and pro-inflammatory cytokines: Protective effect of rutin against toxicantinduced hippocampal injury. Cell Mol Neurobiol 29:523-531
35. Koprich JB, Reske-Nielsen C, Mithal P, Isacson O (2008) Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease. J Neuroinflammation 5:8
36. La Casa C, Villegas I, Alarcon De la Lastra C, Motilva V, Martin Calero MJ (2006) Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol induced gastric lesions. J Ethnopharmacol 71:45-53
37. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG et al (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464-478 (Pubitemid 20279989)
38. Li Y, Hu X, Liu Y, Bao Y, An L (2009) Nimodipine protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation. Neuropharmacology 56:580-589
39. Little JP, Villanueva EB, Klegeris A (2011) Therapeutic potential of cannabinoids in the treatment of neuroinflammation associated with Parkinson's disease. Mini Rev Med Chem 11:582-590
40. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275
41. Meister A (1988) Glutathione metabolism and its selective modification. J Biol Chem 263:17205-17208 (Pubitemid 19029311)
42. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG (1993) A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 214:11-16 (Pubitemid 23300346)
43. Mogi M, Togari A, Tanaka K, Ogawa N, Ichinose H, Nagatsu T (1999) Increase in level of tumor necrosis factor (TNF)-alpha in 6-hydroxydopamine- lesioned striatum in rats without influence of systemic L-dopa on the TNF-alpha induction. Neurosci Lett 268:101-104 (Pubitemid 29287516)
44. Mohandas J, Marshall JJ, Duggin GG, Horvath JS, Tiller D (1984) Differential distribution of glutathione and glutathione related enzymes in rabbit kidneys: Possible implication in analgesic neuropathy. Cancer Res 44:5086-5091
45. Ogura T, Ogata M, Akita H, Jitsuki S, Akiba L, Noda K et al (2005) Impaired acquisition of skilled behaviour in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease. Neurosci Res 51:299-308 (Pubitemid 40248553)
46. Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates, 4th ed. Academic Press, San Diego, CA
47. Pu F, Mishima K, Egashira N, Iwasaki K, Kaneko T, Uchida T et al (2004) Protective effect of buckwheat polyphenols against longlasting impairment of spatial memory associated with hippocampal neuronal damage in rats subjected to repeated cerebral ischemia. J Pharmacol Sci 94:393-402 (Pubitemid 38590759)
48. Pu F, Mishima K, Irie K, Motohashi K, Tanaka Y, Orito K et al (2007) Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats. J Pharmacol Sci 104:329-334 (Pubitemid 47378420)
49. Rozas G, Lopez-Martin E, Guerra MJ, Labandeira-Garcia JL (1998) The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism. J Neurosci Methods 83:165-175 (Pubitemid 28442608)
50. Sánchez-Iglesias S, Méndez-Alvarez E, Iglesias- González J, Munoz-Patino A, Sánchez-Sellero I, Labandeira-García JL et al (2009) Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: Potential effects in a 6-OHDA-induced model of Parkinson's disease. J Neurochem 109:879-888
51. Sauer H, Oertel WH (1994) Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59:401-415 (Pubitemid 24098798)
52. Schwarting RKW, Hudson JL (1996) The unilateral 6-OHDA injection lesion model in behaviour brain research: Analysis of functional deficit, recovery and treatment. Prog Neurobiol 50:275-331 (Pubitemid 26412599)
53. Stevens M, Obrosova I, Cao X, Huysen CV, Green DA (2000) Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism and oxidative stress in experimental diabetic neuropathy. Diabetes 49:1006-1015 (Pubitemid 30349424)
54. Sun Y (1990) Free radicals, antioxidant enzymes and carcinogenesis. Free Rad Biol Med 8:583-599 (Pubitemid 20204421)
55. Tansey MG, McCoy MK, Frank-Cannon TC (2007) Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp Neurol 208:1-25 (Pubitemid 47603240)
56. Utely HC, Bernheim F, Hochslein P (1967) Effect of sulfhydryl reagent on peroxidation in microsome. Arch Biochem Biophys 260:521-531
57. Xue YQ, Zhao LR, Guo WP, Duan WM (2007) Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioural outcome in a rat model of Parkinson's disease. Neuroscience 146:1245-1258
58. Zafar KS, Siddiqui A, Sayeed I, Ahmad M, Salim S, Islam F (2003) Dose-dependent protective effect of selenium in rat model of Parkinson's disease: Neurobehavioural and neurochemical evidences. J Neurochem 84:438-446 (Pubitemid 36182242)